Tag: OTCMKTSESALF

Eisai, Biogen And Alzheimer’s: Never Say Die, Lecanemab To The Rescue (OTCMKTS:ESALF)

In late June I surveyed the end of Aduhelm and looked forward concerning prospects for lecanemab. This week Eisai (OTCPK:ESALY) and Biogen (NASDAQ:BIIB) announced that the Phase 3 CLARITY trial, involving 1,795...

Latest articles

spot_img

Sign up to receive news and updates

To be updated with all the latest news, offers and special announcements.

By signing up you agree to receive email newsletters, notifications and alerts from Covid Dark PRO. You can unsubscribe at any time.
WP2Social Auto Publish Powered By : XYZScripts.com